Kevin London

ORCID: 0000-0003-4639-7966
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Medical Imaging Techniques and Applications
  • Cutaneous Melanoma Detection and Management
  • Glioma Diagnosis and Treatment
  • Radiomics and Machine Learning in Medical Imaging
  • Sarcoma Diagnosis and Treatment
  • Orthopedic Infections and Treatments
  • Meningioma and schwannoma management
  • Medical Imaging and Pathology Studies
  • Bone Tumor Diagnosis and Treatments
  • Histiocytic Disorders and Treatments
  • Neurofibromatosis and Schwannoma Cases
  • Nonmelanoma Skin Cancer Studies
  • Melanoma and MAPK Pathways
  • Osteomyelitis and Bone Disorders Research
  • Brain Metastases and Treatment
  • Hematological disorders and diagnostics
  • AI in cancer detection
  • Lymphoma Diagnosis and Treatment
  • Radiation Dose and Imaging
  • Advanced Radiotherapy Techniques
  • Bone health and treatments
  • Neuroblastoma Research and Treatments
  • Neurological disorders and treatments
  • Vascular Malformations Diagnosis and Treatment
  • Soft tissue tumors and treatment

The University of Sydney
2014-2025

Children's Hospital at Westmead
2015-2025

Sydney Children’s Hospitals Network
2024-2025

Royal Prince Alfred Hospital
2022-2025

Sydney Children's Hospital
2023

Westmead Hospital
2016-2022

Melanoma Institute Australia
2020

Liverpool Hospital
2010

University of York
2002

Abstract Objective. The purpose of this investigation was to explore associations between father-child interactions and children's cognitive status in an underrepresented group low-income, ethnically diverse families. Design. Participants were 65 inner-city fathers their 24-month-old children (34 boys, 31 girls). Father-child videotaped for 10 min at home during semistructured free play, mental scale scores on the Bayley Scales Infant Development obtained children. quality assessed using 14...

10.1207/s15327922par0202_01 article EN Parenting 2002-05-01

Abstract Objective Langerhans cell histiocytosis (LCH) in pediatric patients presents with single‐system or multisystem disease. Accurate staging is essential for selecting the most appropriate therapy ranging from local surgery to chemotherapy. Methods A retrospective review was undertaken of reported fludeoxyglucose (FDG) positron emission tomography ‐ computed (PET‐CT) scans performed children LCH June 2006 February 2017. Findings were compared a reference standard biopsy informed...

10.1002/pbc.28034 article EN Pediatric Blood & Cancer 2019-10-10

Abstract Purpose To investigate the possibility of reducing injected activity for whole-body [18F]FDG-PET/CT studies paediatric oncology patients and to assess usefulness time-of-flight (TOF) acquisition on PET image quality at reduced count levels. Procedures Twenty-nine (12F/17M, 3–18 years old (median age 13y), weight 45±20 kg, BMI 19±4 kg/m 2 ), who underwent routine PET/CT examinations a Siemens Biograph mCT TrueV system with TOF capability (555ps) were included in this study. The mean...

10.1007/s11307-021-01601-4 article EN cc-by Molecular Imaging and Biology 2021-04-12

Abstract Pediatric bronchial carcinoid tumors are rare, accounting for a significant proportion of primary lung in children but only small fraction adults. These can present with symptoms such as cushing's syndrome due to ACTH secretion. Complete surgical resection typically results favorable outcomes, most expressing somatostatin receptors, making them amenable peptide receptor radionuclide therapy (PRRT) (177Lu)Lu-DOTA-TATE (LuTATE). This case report describes 13-year-old female tumor...

10.1055/s-0045-1809341 article EN cc-by World Journal of Nuclear Medicine 2025-05-26

10.1007/s00259-013-2639-9 article EN European Journal of Nuclear Medicine and Molecular Imaging 2013-12-09

To describe the drainage and functional outcome of paediatric pyeloplasty, 1 week after stent removal 7-9 weeks pyeloplasty using diuretic renography.Between 2009 2014, we assessed outcomes according to mercaptoacetyltriglycine MAG-3 renograms from 66 children (69 kidneys) who underwent modified dismembered Anderson-Hynes for pelvi-ureteric junction (PUJ) obstruction. Stents were left in place 6-8 postoperative renal units evaluated with renogram removal. Surgical success was defined by...

10.1111/bju.13512 article EN BJU International 2016-04-22

An 11-year-old girl presented with focal impaired awareness seizures. MRI brain demonstrated a T2 hyperintense cortical lesion in the left temporal lobe surrounding vasogenic edema. 18 F-FDG PET/CT was arranged to assess metabolic activity of cerebral lesion, screen whole body for other metabolically active lesions, and assist biopsy planning. The study intensely increased FDG uptake within without evidence hypermetabolic lesions elsewhere on whole-body acquisition. excised, histopathology...

10.1097/rlu.0000000000005302 article EN Clinical Nuclear Medicine 2024-05-31

Abstract Purpose In sentinel node-positive (SN+ve) melanoma patients, active surveillance with regular ultrasound examination of the node field has become standard, rather than completion lymph dissection (CLND). A proportion these patients now receive adjuvant systemic therapy and have routine cross-sectional imaging (computed tomography [CT] or positron emission [PET]/CT). The role concurrent (US) in is unclear. purpose our study was to describe modality detection nodal recurrence SN+ve...

10.1245/s10434-023-14526-9 article EN cc-by Annals of Surgical Oncology 2023-11-15

A 17-year-old girl with a background of aortic coarctation repaired insertion prosthetic graft presented persisting fever and nonspecific back pain. Whole body Ga-67 scintigraphy was performed to evaluate occult infection. Intense uptake noted in the region superior mediastinum. Fusing tomographic reconstruction CT images allowed accurate determination area enhanced be at site graft.

10.1097/rlu.0b013e31815c50eb article EN Clinical Nuclear Medicine 2008-01-01

TPS9610 Background: Patients diagnosed with stage II melanoma account for ~50% of those who develop metastatic disease and die (Poklepovic et al., 2020). Neoadjuvant therapy (NAT) is a powerful treatment platform to rapidly assess drug activity in resectable cancers using the International Melanoma Consortium (INMC) path response criteria (Tetzlaff 2018), wherein major (≤10% viable tumor) correlates low risk recurrence III (Menzies 2021). Other benefits include early insight into response,...

10.1200/jco.2023.41.16_suppl.tps9610 article EN Journal of Clinical Oncology 2023-06-01
Coming Soon ...